XML 56 R43.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue - Business Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Disaggregation of Revenue [Line Items]        
Revenues $ 852.4 $ 824.0 $ 2,501.4 $ 2,404.5
United States        
Disaggregation of Revenue [Line Items]        
Revenues 642.5 616.7 1,879.7 1,802.5
International        
Disaggregation of Revenue [Line Items]        
Revenues 209.9 207.3 621.7 602.0
Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 305.4 294.2 898.6 858.5
Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 231.2 224.8 685.5 659.5
Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 74.2 69.4 213.1 199.0
Diagnostics | Cytology & Perinatal        
Disaggregation of Revenue [Line Items]        
Revenues 120.3 121.1 353.9 362.2
Diagnostics | Cytology & Perinatal | United States        
Disaggregation of Revenue [Line Items]        
Revenues 78.5 79.6 234.3 242.8
Diagnostics | Cytology & Perinatal | International        
Disaggregation of Revenue [Line Items]        
Revenues 41.8 41.5 119.6 119.4
Diagnostics | Molecular Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 170.9 154.5 502.9 453.8
Diagnostics | Molecular Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 138.5 126.6 409.4 374.2
Diagnostics | Molecular Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 32.4 27.9 93.5 79.6
Diagnostics | Blood Screening        
Disaggregation of Revenue [Line Items]        
Revenues 14.2 18.6 41.8 42.5
Diagnostics | Blood Screening | United States        
Disaggregation of Revenue [Line Items]        
Revenues 14.2 18.6 41.8 42.5
Diagnostics | Blood Screening | International        
Disaggregation of Revenue [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Breast Health        
Disaggregation of Revenue [Line Items]        
Revenues 325.4 307.9 971.6 896.0
Breast Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 261.5 240.0 767.1 696.9
Breast Health | International        
Disaggregation of Revenue [Line Items]        
Revenues 63.9 67.9 204.5 199.1
Breast Health | Breast Imaging        
Disaggregation of Revenue [Line Items]        
Revenues 270.0 256.9 805.6 743.2
Breast Health | Breast Imaging | United States        
Disaggregation of Revenue [Line Items]        
Revenues 214.6 197.2 627.3 568.7
Breast Health | Breast Imaging | International        
Disaggregation of Revenue [Line Items]        
Revenues 55.4 59.7 178.3 174.5
Breast Health | Interventional Breast Solutions        
Disaggregation of Revenue [Line Items]        
Revenues 55.4 51.0 166.0 152.8
Breast Health | Interventional Breast Solutions | United States        
Disaggregation of Revenue [Line Items]        
Revenues 46.9 42.8 139.8 128.2
Breast Health | Interventional Breast Solutions | International        
Disaggregation of Revenue [Line Items]        
Revenues 8.5 8.2 26.2 24.6
Medical Aesthetics        
Disaggregation of Revenue [Line Items]        
Revenues 85.0 91.7 238.6 268.5
Medical Aesthetics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 41.6 48.3 116.5 139.3
Medical Aesthetics | International        
Disaggregation of Revenue [Line Items]        
Revenues 43.4 43.4 122.1 129.2
GYN Surgical        
Disaggregation of Revenue [Line Items]        
Revenues 112.2 107.7 322.8 314.7
GYN Surgical | United States        
Disaggregation of Revenue [Line Items]        
Revenues 92.8 89.0 268.0 262.9
GYN Surgical | International        
Disaggregation of Revenue [Line Items]        
Revenues 19.4 18.7 54.8 51.8
Skeletal Health        
Disaggregation of Revenue [Line Items]        
Revenues 24.4 22.5 69.8 66.8
Skeletal Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 15.4 14.6 42.6 43.9
Skeletal Health | International        
Disaggregation of Revenue [Line Items]        
Revenues $ 9.0 $ 7.9 $ 27.2 $ 22.9